IP Library Patent Application 18295924
Patent Application
App. No. 18/295,924

PROBES FOR DETECTING CANDIDA GLABRATA

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/295,924
Abstract

Disclosed are methods utilizing specific amplification of Candida sp. target nucleic acid for detecting the presence or absence of Candida sp. in a sample. Also disclosed are corresponding oligomers, including amplification oligomers, capture probes and detection probes, and combinations thereof, as well as corresponding reaction mixtures and kits.

Claims (39)

1 . A detection probe for detecting a Candida ( C. ) glabrata target nucleic acid, said detection probe comprising

(a) a C. glabrata -specific detection probe target-hybridizing sequence consisting of a sequence selected from the group consisting of

the sequence of residues 1-17 of SEQ ID NO:60,

the sequence of residues 1-23 of SEQ ID NO:45,

the sequence of residues 1-17 of SEQ ID NO:18,

the sequence of residues 1-20 of SEQ ID NO:21,

the DNA equivalent or an RNA/DNA chimeric of any of the foregoing, and

the full complement of any of the foregoing; and

(b) at least one of

a label,

a substitution at the 2′ position of at least one ribose moiety, and

a blocking group at or near the 3′ end of the detection probe.

2 . The detection probe of claim 1 , wherein the detection probe has a sequence selected from the group consisting of the sequence of SEQ ID NO:60, SEQ ID NO:45, SEQ ID NO:18, SEQ ID NO:21, the DNA equivalent or an RNA/DNA chimeric of any of the foregoing, and the full complement of any of the foregoing.

3 . The detection probe of claim 1 , wherein the detection probe comprises the label.

4 . The detection probe of claim 3 , wherein the label is a chemiluminescent label or a fluorescent label.

5 . The detection probe of claim 3 , wherein the detection probe comprises a fluorescent label and a quencher.

6 . The detection probe of claim 5 , wherein the detection probe is a molecular torch, a molecular beacon, or a TaqMan detection probe.

7 . The detection probe of claim 1 , wherein the detection probe further comprises a non-target-hybridizing sequence.

8 . The detection probe of claim 7 , wherein the detection probe is a molecular torch or a molecular beacon.

9 . The detection probe of claim 1 , wherein the detection probe comprises the substitution at the 2′ position of at least one ribose moiety.

10 . The detection probe of claim 9 , wherein the substitution at the 2′ position of at least one ribose moiety is a 2′ methoxy substitution.

11 . The detection probe of claim 1 , wherein the detection probe comprises the blocking group at or near the 3′ end of the detection probe.

12 . The detection probe of claim 11 , wherein the blocking group is selected from the group consisting of an alkyl group, a non-nucleotide linker, an alkane-diol dideoxynucleotide residue, and cordycepin.

13 . A kit comprising the detection probe of claim 1 .

14 . The kit of claim 13 , further comprising at least one of

(i) an amplification oligomer combination for amplification of a C. glabrata nucleic acid target region, wherein the detection probe is capable of binding to said target region; and

(ii) a capture probe oligomer for purifying the C. glabrata target nucleic acid.

15 . The kit of claim 13 , further comprising a Candida -specific detection probe for detecting a Candida species (sp.) target nucleic acid from one or more of C. albicans, C. paripsolosis, C. dubliniensis , and C. tropicalis.

16 . The kit of claim 15 , further comprising at least one of

(i) an amplification oligomer combination for amplification of a Candida sp. nucleic acid target region, wherein said target region is from one or more of C. albicans, C. paripsolosis, C. dubliniensis , and C. tropicalis , and wherein the Candida -specific detection probe is capable of binding to said target region; and

(ii) a capture probe oligomer for purifying the Candida sp. target nucleic acid.

17 . A reaction mixture comprising the detection probe of claim 1 .

18 . The reaction mixture of claim 17 , further comprising at least one of

(i) an amplification oligomer combination for amplification of a C. glabrata nucleic acid target region, wherein the detection probe is capable of binding to said target region; and

(ii) a capture probe oligomer for purifying the C. glabrata target nucleic acid.

19 . The reaction mixture of claim 17 , further comprising a Candida -specific detection probe for detecting a Candida species (sp.) target nucleic acid from one or more of C. albicans, C. paripsolosis, C. dubliniensis , and C. tropicalis.

20 . The reaction mixture of claim 19 , further comprising at least one of

(i) an amplification oligomer combination for amplification of a Candida sp. nucleic acid target region, wherein said target region is from one or more of C. albicans, C. paripsolosis, C. dubliniensis , and C. tropicalis , and wherein the Candida -specific detection probe is capable of binding to said target region; and

(ii) a capture probe oligomer for purifying the Candida sp. target nucleic acid.

Assignments (4)
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 065286/0407 Recorded Apr 24, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC.; GEN-PROBE INCORPORATED; FAXITRON BIOPTICS, LLC; BIOTHERANOSTICS, INC.; GEN-PROBE PRODESSE, INC.
Reel/Frame 075457/0767 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2024
From: HUDSON, ANGELA S.; GETMAN, DAMON K.; JIANG, ALICE; EATON, BARBARA L.
To: GEN-PROBE INCORPORATED
Reel/Frame 066578/0758 →
SECURITY INTEREST Recorded Oct 19, 2023
From: HOLOGIC, INC.; FAXITRON BIOPTICS, LLC; BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 065286/0407 →